Therapeutic efficacy of INX-315, a selective CDK2 inhibitor, in solid tumors

NIAID Data Ecosystem2026-05-02 收录

CDK2抑制剂

实体瘤治疗

数据链接：

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE243154 数据链接链接失效反馈

官方服务：

资源简介：

This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

创建时间：

2025-05-06

腔道粒子支架植入剂量计算数据集

放疗剂量

实体瘤治疗

本数据集是针对BrachyTPS软件的剂量计算模块对非实体肿瘤的剂量计算结果的开发和验证。非实体肿瘤不同于有具体形态的实体肿瘤，在进行近距离放疗时需要使用粒子支架，所以剂量计算程序于实体瘤有一定的差别。针对腔道粒子支架植入剂量计算，我们使用两种放射性粒子125I粒子、复合粒子分别使用BrachyTPS软件进行剂量计算以及蒙特卡洛开源软件Gate8 .2进行剂量计算，争取对该软件的剂量计算模块进行全

国家基础学科公共科学数据中心120

S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers

实体瘤治疗

药物疗效评估

The purpose of the study is to investigate the safety, tolerability, and preliminary anti-neoplastic activity of S095029 alone and in combination with Sym021 in patients with advanced solid tumor mali

NIAID Data Ecosystem50

Table 3 from Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors

临床药物安全性

实体瘤治疗

Summary of AEs.

Figshare2025-09-17 更新40

Patient characteristics (n = 104). *

肿瘤DNA检测

实体瘤治疗

*One patient was subsequently found to be ineligible for this study as he had not exhausted all lines of available antitumor treatments. **Includes non-small cell lung cancer (NSCLC), mesothelioma, sa

NIAID Data Ecosystem50

Table 3 from Phase I Study of Simlukafusp Alfa (FAP-IL2v) with or without Atezolizumab in Japanese Patients with Advanced Solid Tumors

药代动力学

实体瘤治疗

Summary of PK parameters

NIAID Data Ecosystem40